FEATURED

COVID 19 Articles

Trending COVID 19 News

Certara, Inc. Q2 2026 Earnings Call Summary

Certara pivoted to a specialist sales model and divested its regulatory business, with software now representing 53% of revenue. The company reaffirmed full-year guidance of 0% to 4% growth while expanding margins.

read more

Revvity, Inc. Q2 2026 Earnings Call Summary

Revvity reported Q2 2026 earnings beat driven by strong pharma and biotech spending, with rising demand for AI-driven drug discovery platforms and raised full-year organic growth guidance to 4-5%.

read more